- Home
- SOPH vs MGTX Comparison
SOPH vs MGTX Comparison
Compare SOPH & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- MGTX
- Stock Information
- Founded
- SOPH 2011
- MGTX 2015
- Country
- SOPH Switzerland
- MGTX United States
- Employees
- SOPH N/A
- MGTX N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOPH Health Care
- MGTX Health Care
- Exchange
- SOPH Nasdaq
- MGTX Nasdaq
- Market Cap
- SOPH 247.0M
- MGTX 411.4M
- IPO Year
- SOPH 2021
- MGTX N/A
- Fundamental
- Price
- SOPH $3.40
- MGTX $5.98
- Analyst Decision
- SOPH Strong Buy
- MGTX Strong Buy
- Analyst Count
- SOPH 3
- MGTX 2
- Target Price
- SOPH $7.00
- MGTX $22.50
- AVG Volume (30 Days)
- SOPH 21.9K
- MGTX 325.1K
- Earning Date
- SOPH 11-05-2024
- MGTX 11-12-2024
- Dividend Yield
- SOPH N/A
- MGTX N/A
- EPS Growth
- SOPH N/A
- MGTX N/A
- EPS
- SOPH N/A
- MGTX N/A
- Revenue
- SOPH $64,938,000.00
- MGTX $8,122,000.00
- Revenue This Year
- SOPH $7.70
- MGTX $133.83
- Revenue Next Year
- SOPH $20.61
- MGTX $655.34
- P/E Ratio
- SOPH N/A
- MGTX N/A
- Revenue Growth
- SOPH 20.14
- MGTX 26.87
- 52 Week Low
- SOPH $2.70
- MGTX $3.49
- 52 Week High
- SOPH $7.37
- MGTX $7.60
- Technical
- Relative Strength Index (RSI)
- SOPH 44.10
- MGTX 78.17
- Support Level
- SOPH $3.22
- MGTX $3.97
- Resistance Level
- SOPH $3.66
- MGTX $6.24
- Average True Range (ATR)
- SOPH 0.20
- MGTX 0.33
- MACD
- SOPH 0.01
- MGTX 0.20
- Stochastic Oscillator
- SOPH 58.60
- MGTX 88.56
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.